Company intelligence / Profile preview

Effexus Pharmaceutical

Unknown, Kansas, United Statesstatnews.com ↗

Ownership: Private
Development stage: Other

Overview

Effexus Pharmaceutical is a private pharmaceutical company based in Kansas, United States. Its lead clinical asset is a combination of lansoprazole and omeprazole targeting the proton pump for gastrointestinal indications such as Barrett esophagus and erosive esophagitis. The company has conducted at least three clinical trials with its main program reaching Phase 2. There are no recent reports of commercialized products or late-stage assets[1].

Therapeutic areas: GastroenterologyOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Effexus Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Effexus Pharmaceutical.

Explore the full profile